Compass Pathways Appoints a New CEO

Compass Pathways Appoints a New CEO

George Goldsmith will be replaced as Compass Pathways CEO. Is this good or bad news?

The Battle for Psychedelic Patents

Psychedelic companies rely on novel patents to boost their value, but many players in the space are chasing the same IP

Psychedelic Business Spotlight – July 1

,
This week in psychedelic stock news: MindMed downplays delisiting fears; Red Light Holland teams with Wiz Khalifa; Field Trip shareholders approve company split; and more!

Wiz Khalifa Teams Up With Red Light Holland for Boutique Mushroom Brand

,
The rapper known for his cannabis advocacy has partnered with Red Light Holland to launch a mushroom wellness brand called MISTERCAP
Psychedelic Business Spotlight – June 24

This Week in Psychedelic Stocks: Compass Pathways Wins Patent Battle, MindMed Patents Candy Flipping, and More!

,
This week in psychedelic stock news, there are big patent developments for Compass, MindMed and Numinus.
Compass Pathways Psilocybin Patent Upheld

Compass Pathways Psilocybin Patent Upheld

Compass Pathways scores a major victory in their bid to patent Comp 360, a proprietary formulation of psilocybin.
Psychedelic Business Spotlight - June 17

Psychedelic Business Spotlight – June 17

,
This week in psychedelic business news: ARK Invest advances deep dive into psychedelic stocks; Cybin moves closer to clinical trials, and more!
The Four Psychedelics ETFs Capturing Investor Attention

The Four Psychedelics ETFs Capturing Investor Attention

Despite an overarching shared thesis, the four psychedelics ETFs differ in philosophy, strategy, execution, and size. This leads them to having different sized stakes companies, and their long-term success will vary.

Psychedelic Capitalism Takes a Trip to Davos

From May 21-26, for the first time, the Davos Forum will feature The House of Psychedelics. Here's why that matters for the psychedelics industry.
MindMed, atai Life Sciences, Compass Pathways: A Psychedelic Stock AnalysisShutterstock

Comparing MindMed, Atai Life Sciences, Compass Pathways: A Psychedelic Stock Analysis

,
Our resident psychedelic investor explains a handful of important metrics to study when analyzing and comparing psychedelic stocks.